News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of NST-4016 in Patients With Nonalcoholic Steatohepatitis (NASH)

Study Status:

Active

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

The primary objective of this study is to evaluate the efficacy of different doses of NST-4016 on the resolution of NASH without worsening of fibrosis. The secondary objective is to determine the safety and tolerability of NST-4016 in patients with NASH.

Information: 

Principal Investigator
Sriramachandra Badiga, MD
Type of Trial
Prospective/Interventional
DHRHealth Institute for Research and Development
5323 S. McColl Rd., Edinburg, TX 78539
(956) 362-2390
© 2022 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank